Fortress Biotech
Manufacturing · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1111 Kane Concourse Ste 301, Bay Harbor ...Phone Number
(781) 652-4500Website
www.fortressbiotech.comRevenue
$66.2 MillionStock Symbol
FBIOIndustry
About Fortress Biotech
Fortress Biotech Org Chart
Is Fortress Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Fortress Biotech recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Fortress Biotech has new funding data
Website visits: Recent activity has been detected on your website
Check out if Fortress Biotech is spiking on competitors!
Check if Fortress Biotech has recently received funding, and reach out quickly before it becomes old news!
Click to see if Fortress Biotech had a recent Job posting/layoffs
Product Launch: Get notified when Fortress Biotech launches new products
Congratulate Masked Content for being promoted to Masked Content at Fortress Biotech
Fortress Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Fortress Biotech as Masked Content
Find 2 more new buyers
Compare Similar Companies to Fortress Biotech
Compare insights from companies similar to Fortress Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fortress Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Fortress Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Fortress Biotech.
Fortress Biotech financials insights
Gather financial insights about Fortress Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Debt
$15M
Debt
$60M
Share Placement
$10M
Fortress Biotech Tech Stack
A closer look at the technologies used by Fortress Biotech
Most Recent Scoops
Fortress Biotech News & Media
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Total net revenue increased 14% to $18.7 million for second quarter of 2026 compared to second quarter of 2025SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duties by Certain Officers and Directors of Fortress Biotech, Inc. (NASDAQ: FBIO)
NEW YORK, Aug. 7, 2026 /PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Fortress Biotech, Inc. (NASDAQ: FBIO) concerning possible breaches of fiduciary duties. If you are a current shareholder of FBIO, you can obtain additional information here:...Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys ... - Yahoo Finance
Proceeds to support ongoing late-stage global clinical development and commercialization preparation of dotinurad, a next-generation, once daily, oral URAT1 inhibitor with the potential to deliver best-in-class safety and efficacy for the treatment of goutMIAMI, July 27, 2026 (GLOBE NEWSWIRE) -- Urica Therapeutics, Inc. (“Urica” or the “Company”), a Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) subsidiary, today announced that Crystalys Therapeutics, Inc. (“Crystalys”), in which Urica maintFortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Proceeds to support ongoing late-stage global clinical development and commercialization preparation of dotinurad, a next-generation, once daily, oral URAT1 inhibitor with the potential to deliver best-in-class safety and efficacy for the treatment of gout Proceeds to support ongoing late-stage global clinical development and commercialization preparation of dotinurad, a next-generation, once daily, oral URAT1 inhibitor with the potential to deliver best-in-class safety and efficacy for the trea
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fortress Biotech
Founded in 2006, Fortress Biotech is a biopharmaceutical company that focuses on acquiring, developing, and commercializing high-potential marketed pharmaceutical products and development-stage pharmaceutical product candidates. The company is headquartered in Bay Harbor Islands, Florida.... Read More

